PolyPeptide Group AG (LON:0AAJ)
London · Delayed Price · Currency is GBP · Price in CHF 25.60
-0.55 (-2.09%)
At close: Oct 30, 2025
PolyPeptide Group AG Market Cap
PolyPeptide Group AG has a market cap or net worth of 813.06 million as of October 31, 2025. Its market cap has decreased by -0.82% in one year.
Market Cap
813.06M
Enterprise Value
843.71M
Revenue
316.17M
Ranking
n/a
PE Ratio
n/a
Stock Price
25.60
Market Cap Chart
Since April 29, 2021, PolyPeptide Group AG's market cap has decreased from 2.04B to 813.06M, a decrease of -60.13%. That is a compound annual growth rate of -18.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 801.40M | -2.90% |
| Dec 30, 2024 | 825.31M | 53.37% |
| Dec 29, 2023 | 538.12M | -28.11% |
| Dec 30, 2022 | 748.55M | -79.59% |
| Dec 30, 2021 | 3.67B | 79.84% |
| Apr 29, 2021 | 2.04B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 194.77B |
| GSK plc | 70.40B |
| Haleon | 31.24B |
| Smith & Nephew | 11.60B |
| ConvaTec Group | 4.82B |
| Hikma Pharmaceuticals | 4.04B |
| HUTCHMED (China) | 1.88B |
| Genus | 1.68B |